Children, Adolescents and Young Adults with Myeloproliferative Neoplasia: Study of Clinico-biological Characteristics and Complications (VYP)

Children, Adolescents and Young Adults with Myeloproliferative Neoplasia: Study of Clinico-biological Characteristics and Complications

The creation of a national database will provide access to solid data on the diagnosis of myeloproliferative neoplasia for patients under 30, giving a true picture of their care. It will also make it possible to identify the biological samples (histological and molecular) available in routine laboratories, enabling teams of researchers and anatomopathologists to (re)perform certain analyses to re-evaluate diagnoses and search for hitherto unknown molecular prognostic factors.

Inclusion Criteria:

• Patient diagnosed with non-LMC MPN before the age of 30 (PV or TE or MFP or PreMF) according to the 2016 WHO criteria.
• Signature of the consent form for participation in the FIMBANK project.
• Agreement to participate in the VYP study.
• Patient of legal age at the time of inclusion in VYP.
• Patient affiliated to a social security scheme

Exclusion Criteria:

• Refusal to participate by patients of full age
• Patient under legal protection (guardianship, curatorship, etc.)